insights_auto
Why is INO down 3,97%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,45 USD
arrow_downward
-3,97%(-0,060) 1D
1,36 USD
arrow_downward
-6,21% (-0,090)bedtimeAfter hours
Closed: 10-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,48 USD
High
1,51 USD
Low
1,40 USD
Mkt. cap
244,95 млн
Avg. vol.
18,40 млн
Volume
14,45 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,48 USD
High
1,51 USD
Low
1,40 USD
Mkt. cap
244,95 млн
Avg. vol.
18,40 млн
Volume
14,45 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
Investing.com Canada
·
45 мүнөт мурун
Inovio Q3 2026 slides: VOCERYQ approval amid wider loss By Investing.com
The Business Journals
·
1 саат мурун
2 life sciences companies raise $86M each in public stock sales
TradingView
·
1 саат мурун
INO: VOCERYQ approval launches a new commercial phase, backed by financing and a late-2027 runway outlook
Investing.com India
·
1 саат мурун
Earnings call transcript: Inovio posts wider-than-expected Q3 2026 loss as launch begins By Investing.com
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc